WASHINGTON — The Food and Drug Administration and Abbott Nutrition have agreed on a plan to resume operations at its infant formula facility in Sturgis, Michigan, the company announced on Monday.
While the news will be welcomed by frustrated dealing who are struggling find formula on shelves, it still could be several more weeks before they see relief.
According to Abbott, the agreement with the FDA lays out"the steps necessary to resume production and maintain the facility” but remains subject to court approval. Abbott said that once the FDA gives it the official green light, it could restart operations at the site within two weeks and that it would take six to eight weeks after that before the product is back on shelves.
"Our number one priority is getting infants and families the high-quality formulas they need, and this is a major step toward re-opening our Sturgis facility so we can ease the nationwide formula shortage. We look forward to working with the FDA to quickly and safely re-open the facility," said Robert B. Ford, chairman and chief executive officer of Abbott.
It’s estimated that Abbott Nutrition is one of only four companies that controls 90 percent of the market. The industry was already dealing with supply chain issues when federal inspectors found evidence of a deadly bacteria at the Sturgis plant and shut it down. Abbott maintains that there is still no evidence linking its formula to four infant illnesses, which included two deaths.Copyright © 2022, ABC Audio. All rights reserved.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA, Abbott agree on plan to resume production of infant formula at Michigan plantBREAKING: FDA and Abbott Nutrition agree on plan to resume operations at its infant formula facility in Sturgis, Michigan, the company announces.
Read more »
Baby formula maker Abbott says agreement reached with FDA to reopen Sturgis, Michigan facilityAfter production resumes, Abbott has said it will take at least eight weeks to begin shipping new product to stores.
Read more »
Abbott reaches deal with FDA to reopen Michigan baby formula plantThe White House said it is working with all major formula producers to boost production, including reaching out to their suppliers to encourage them to prioritize production and delivery of formula ingredients.
Read more »
White House Says Deal Near to Reopen Abbott Baby Formula Plant in MichiganThe Biden’s administration is expected to announce an agreement to reopen the largest domestic manufacturing plant of infant formula and to ease import rules to allow supplies in from overseas, amid a nationwide shortage spurred by the Michigan plant’s shutdown earlier this year over safety issues.
Read more »
Abbott agrees to consent decree with FDA, could restart plant within 2 weeks, pending court approvalThe baby formula manufacturer at the heart of a nationwide recall says it has reached an agreement with the FDA on steps necessary to resume production at its shuttered plant.
Read more »